Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

213 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Systematic review of combinations of targeted or immunotherapy in advanced solid tumors.
Tan AC, Bagley SJ, Wen PY, Lim M, Platten M, Colman H, Ashley DM, Wick W, Chang SM, Galanis E, Mansouri A, Khagi S, Mehta MP, Heimberger AB, Puduvalli VK, Reardon DA, Sahebjam S, Simes J, Antonia SJ, Berry D, Khasraw M. Tan AC, et al. Among authors: antonia sj. J Immunother Cancer. 2021 Jul;9(7):e002459. doi: 10.1136/jitc-2021-002459. J Immunother Cancer. 2021. PMID: 34215688 Free PMC article. Review.
Immune Checkpoint Inhibitors in the Aged.
Isaacs J, Antonia S, Clarke J. Isaacs J, et al. Curr Oncol Rep. 2021 Aug 3;23(10):115. doi: 10.1007/s11912-021-01106-x. Curr Oncol Rep. 2021. PMID: 34342733 Review.
Patient-derived micro-organospheres enable clinical precision oncology.
Ding S, Hsu C, Wang Z, Natesh NR, Millen R, Negrete M, Giroux N, Rivera GO, Dohlman A, Bose S, Rotstein T, Spiller K, Yeung A, Sun Z, Jiang C, Xi R, Wilkin B, Randon PM, Williamson I, Nelson DA, Delubac D, Oh S, Rupprecht G, Isaacs J, Jia J, Chen C, Shen JP, Kopetz S, McCall S, Smith A, Gjorevski N, Walz AC, Antonia S, Marrer-Berger E, Clevers H, Hsu D, Shen X. Ding S, et al. Cell Stem Cell. 2022 Jun 2;29(6):905-917.e6. doi: 10.1016/j.stem.2022.04.006. Epub 2022 May 3. Cell Stem Cell. 2022. PMID: 35508177 Free PMC article.
A Phase 2 Clinical Trial of Combination Nivolumab, Ipilimumab, and Paclitaxel in Patients With Untreated Metastatic NSCLC: The OPTIMAL Trial.
Clarke JM, Gu L, Wang XF, Stinchcombe TE, Stevenson MM, Ramalingam S, Shariff A, Garst J, Nixon AB, Antonia SJ, Crawford J, Ready NE. Clarke JM, et al. Among authors: antonia sj. JTO Clin Res Rep. 2022 May 17;3(6):100337. doi: 10.1016/j.jtocrr.2022.100337. eCollection 2022 Jun. JTO Clin Res Rep. 2022. PMID: 35719867 Free PMC article.
The bottleneck effect in lung cancer clinical trials.
Gonzalez LE, Sutton SK, Pratt C, Gilbertson M, Antonia S, Quinn GP. Gonzalez LE, et al. J Cancer Educ. 2013 Sep;28(3):488-93. doi: 10.1007/s13187-013-0491-z. J Cancer Educ. 2013. PMID: 23733149 Free PMC article. Clinical Trial.
HDAC Inhibitors Enhance T-Cell Chemokine Expression and Augment Response to PD-1 Immunotherapy in Lung Adenocarcinoma.
Zheng H, Zhao W, Yan C, Watson CC, Massengill M, Xie M, Massengill C, Noyes DR, Martinez GV, Afzal R, Chen Z, Ren X, Antonia SJ, Haura EB, Ruffell B, Beg AA. Zheng H, et al. Among authors: antonia sj. Clin Cancer Res. 2016 Aug 15;22(16):4119-32. doi: 10.1158/1078-0432.CCR-15-2584. Epub 2016 Mar 10. Clin Cancer Res. 2016. PMID: 26964571 Free PMC article.
213 results